Seeking safer drug mix for kids battling HIV and TB
NCT ID NCT05069688
Summary
This study aims to understand how two key drugs, dolutegravir and rifampicin, interact in the bodies of young children who have both HIV and tuberculosis (TB). Researchers will measure drug levels in 20 children under 6 years old in Nigeria to see if a higher dose of the TB drug is safe and effective when given with the HIV medication. The goal is to gather data to help doctors prescribe the best possible doses for children with this dangerous combination of infections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University College Hospital/ University of Ibadan
RECRUITINGIbadan, Oyo State, Nigeria
Contact
Conditions
Explore the condition pages connected to this study.